Inhaled Bronchodilators: indications and administration techniques among patients on ventilatory support

Authors

  • Lionel Tchatat Université de Tours, Faculté de médecine, CHRU de Tours, Service de Médecine Intensive Réanimation, réseau CRICS-Triggersep, Tours, France
  • Hélène Messet Université de Tours, Faculté de médecine, 37000 Tours, France et CHR d’Orléans, Service de Médecine Intensive Réanimation, réseau CRICS-Triggersep, Orléans, France
  • Misylias Bouaoud Université de Tours, Faculté de médecine, 37000 Tours, France et CHR d’Orléans, Service de Médecine Intensive Réanimation, réseau CRICS-Triggersep, Orléans, France
  • Stephan Ehrmann Université de Tours, INSERM, Centre d’étude des pathologies respiratoires UMR 1100, CHRU de Tours, Service de Médecine Intensive Réanimation, CIC 1415, réseau CRICS-Triggersep, Tours, France

DOI:

https://doi.org/10.37051/mir-00026

Keywords:

Albuterol, Ipratropium, critical care, intensive care units, administration, inhalation

Abstract

Many bronchodilator drugs are available for inhaled administration using nebulizers or metered dose inhalers; the molecules most evaluated in the context of ventilatory support being salbutamol and ipratropium which have a short duration of action. Bronchodilators are frequently used in intensive care units mainly for the treatment of acute exacerbations of chronic obstructive pulmonary diseases, despite the absence of a high level of evidence regarding their benefit on patient-centered outcomes. Their therapeutic index is broad with a physiological efficacy observed for low doses and a good tolerance, even at high doses. Nevertheless, some cardiovascular adverse effects may occur even after inhaled pulmonary administration. Administration modalities are different depending on the type of ventilatory support but are generally simple whether it is during non-invasive ventilation, nasal high flow therapy or invasive ventilation, because of the broad therapeutic index not requiring any optimization technique. Beyond clinical monitoring during administration, placement of a filter on the expiratory limb protecting the ventilator is an important safety measure.

Published

2020-10-12

How to Cite

Tchatat, L., Messe, H., Bouaoud, M., & Ehrmann, S. (2020). Inhaled Bronchodilators: indications and administration techniques among patients on ventilatory support. Médecine Intensive Réanimation. https://doi.org/10.37051/mir-00026

Issue

Section

Update

Most read articles by the same author(s)

  • Philippe Le Conte, Nicolas Terzi, Guillaume Mortamet, Fekri Abroug, Guillaume Carteaux, Céline Charasse, Anthony Chauvin, Xavier Combes, Stéphane Dauger, Alexandre Demoule, Thibaut Desmettre, Stéphan Ehrmann, Bénédicte Gaillard-Le Roux, Valérie Hamel, Boris Jung, Sabrina Kepka, Erwan L’Her, Mikaël Martinez, Christophe Milési, Élise Morawiec, Mathieu Oberlin, Patrick Plaisance, Robin Pouyau, Chantal Raherison, Patrick Ray, Matthieu Schmidt, Arnaud W Thille, Jennifer Truchot, Guillaume Valdenaire, Julien Vaux, Damien Viglino, Guillaume Voiriot, Bénédicte Vrignaud, Sandrine Jean, Eric Mariotte, Pierre-Géraud Claret, Management of severe asthma exacerbation , Médecine Intensive Réanimation: Vol. 29 No. 2 (2020): Avril-Juin 2020